Logo VOLVOX Therapeutics GmbH
  • Siegestor München Banner Volvox Therapeutics

Dr. Samson Fung, CEO & Managing Director

Samson is a board certified internist with 15+ years experience in the pharmaceutical industry with a long track record in different leadership positions in several big and midsize pharmaceutical companies. Before founding Volvox he was working as a Consultant to some of the most successful biotech companies. Before starting his consultancy business he held senior positions at Roche, Novartis, Pfizer, Novo Nordisk and Astra Zeneca and was Senior Medical Director at Micromet/Amgen. As Head of Clinical Development at MorphoSys he was also part of the team that successfully outlicensed MOR202 to Celgene (upfront > 90 m$, total > 600 m$).

He received his M.D. and doctorate from the University of Freiburg.

Dr. Harald Haeske, Chief Medical Officer and Chief Business Officer, Managing Director

Harald is a board certified internist with 8+ years significant experience in the pharmaceutical industry in different areas as Corporate Drug Safety, Clinical Operations & Clinical Development. Before founding Volvox he was working at MorphoSys and was leading as Clinical Program Lead their two most successful programs MOR202 & MOR208. He was also part of the team that successfully outlicensed MOR202 to Celgene.

He received his M.D. and doctorate from the University of Marburg.